Thiocarlide

Thiocarlide

Structural formula of thiocarlide
Space-filling model of the thiocarlide molecule
Systematic (IUPAC) name
1,3-bis[4-(3-methylbutoxy)phenyl]thiourea
Identifiers
CAS Number	910-86-1 N
ATC code	J04AD02 (WHO)
PubChem	CID: 3001386
ChemSpider	2272774 Y
UNII	43M23X81Y2 Y
ChEMBL	CHEMBL214920 Y
Chemical data
Formula	C23H32N2O2S
Molecular mass	400.578 g/mol
SMILES S=C(Nc1ccc(OCCC(C)C)cc1)Nc2ccc(OCCC(C)C)cc2
InChI InChI=1S/C23H32N2O2S/c1-17(2)13-15-26-21-9-5-19(6-10-21)24-23(28)25-20-7-11-22(12-8-20)27-16-14-18(3)4/h5-12,17-18H,13-16H2,1-4H3,(H2,24,25,28) Y Key:BWBONKHPVHMQHE-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Thiocarlide (or tiocarlide or isoxyl) is a thiourea drug used in the treatment of tuberculosis, inhibiting synthesis of oleic acid and tuberculostearic acid.

Thiocarlide has considerable antimycobacterial activity in vitro and is effective against multi-drug resistant strains of Mycobacterium tuberculosis. Isoxyl inhibits M. bovis with six hours of exposure, which is similar to isoniazid and ethionamide, two other prominent anti-TB drugs. Unlike these two drugs, however, isoxyl also partially inhibits the synthesis of fatty acids.

Thiocarlide was developed by a Belgian company, Continental Pharma S.A. Belgo-Canadienne in Brussels, Belgium. The head researcher was Professor N. P. Buu-Hoi, head of Continental Pharma's Research Division.